In a regulatory filing, Charles River (CRL) said that on May 16, 2023, the company received an inquiry from the Enforcement Division of the U.S. Securities and Exchange Commission requesting it to voluntarily provide information, subsequently augmented with a document subpoena and additional inquiries, primarily related to the sourcing of non-human primates and related disclosures. In addition, the company’s Audit Committee retained counsel to conduct an independent investigation into certain issues raised in the investigation. On November 14, 2025, the SEC’s Division of Enforcement notified the company that it concluded its investigation and, based on the information available to the Division, it does not intend to recommend an enforcement action by the SEC against the company. Similarly, the company’s independent investigation into these matters has also concluded, with no material findings.
TipRanks Cyber Monday Sale
- Claim 60% off TipRanks Premium for data-backed insights and research tools you need to invest with confidence.
- Subscribe to TipRanks' Smart Investor Picks and see our data in action through our high-performing model portfolio - now also 60% off
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on CRL:
- Charles River price target raised to $185 from $170 at Morgan Stanley
- Charles River price target lowered to $197 from $205 at TD Cowen
- Buy Rating for Charles River Labs: Potential Upside Amid Dynamic Environment and Favorable Trends
- Charles River price target raised to $165 from $160 at JPMorgan
- Charles River upgraded to Outperform from Neutral at Baird
